drugset / Trial / NCT04320706

Oral Oxytocin Modulation of Responses to Emotional Stimuli

NCT04320706 ↗

RandomizedParallel-groupTriple-blindBasic science

Summary

The main aim of the study is to investigate whether orally administered oxytocin (24IU) can modulate neural and behavioral responses to positive and negative valence stimuli during basal (emotional scenes) and higher order (facial stimuli) emotional processing.

Timeline

Start
2020-02-20
Primary completion
2020-12-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Oral

Indications

No indication recorded.